Surgical treatment of secondary hyperparathyroidism due to chronic kidney disease

Upsala Journal of Medical Sciences

Volumn 111, Issue 3, 2006, Pages 277-292

  Tominaga, Yoshihiro ^a  

^a NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOTRANSPLANTATION; CALCIUM INTAKE; CHRONIC KIDNEY FAILURE; HUMAN; JAPAN; METHODOLOGY; MORTALITY; PARATHYROID GLAND; PARATHYROIDECTOMY; PATHOLOGY; PATHOPHYSIOLOGY; RECURRENT DISEASE; REVIEW; SECONDARY HYPERPARATHYROIDISM; TRANSPLANTATION; UTILIZATION REVIEW;

CALCIUM, DIETARY; HUMANS; HYPERPARATHYROIDISM, SECONDARY; JAPAN; KIDNEY FAILURE, CHRONIC; PARATHYROID GLANDS; PARATHYROIDECTOMY; RECURRENCE; TRANSPLANTATION, AUTOLOGOUS;

EID: 34548428380     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: 10.3109/2000-1967-047     Document Type: Review

References (79)

1. Johansson H (1994). History of parathyroid operation and reoperation. pp1-7, Akerstrom G, R.G.Landes Company USA.
2. Nakai S, Wada A, Kitaoka K, et al. (2005). An overview of dialysis treatment in Japan (as of Dec.31,2002) Tousekikaishi 39:1-22.
3. Patient Registration Committee (2004). Japanese Society for Dialaysis Therapy: An overview of regular dialysis treatment in Japan (as of 31 December 2001) Ther Apher Dial 8:1-32.
4. An overview of dialysis treatment in Japan (as of Dc.31, 1997)
5. Young EW, Albert JM, Satayathum S, et al. (2005). Predictor and consequences of altered mineral metabolism:The Dialysis Outcomes and Practice Patterns Study. Kidney Int 67:1179-1187.
6. Slatopolsky E, Brown A, Dusso A (1997). Pathogenesis of secondary hyperparathyroidism. Kidney Int Suppl. 73:S14-S19.
7. Slatopolsky E, Finch J, Denda M, et al. (1996). Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 97:2534-2540.
8. Fukuda N, Tanaka H, Tominaga Y, et al. (1993). Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 92:1436-1443.
9. Gogusev J, Duchambon P, Hory B, et al. (1997). Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int 51:328-336.
10. Slatopolsky E, Finch L, Clay P et al. (2000). A novel mechanism for skeletal resistance in uremia. Kidney Int 58:753-761.
11. Tominaga Y, Sato K, Numano M, Uchida K, Takagi H (1995). Histopathology and pathophysiology of secondary hyperparathyroidism due to chronic renal failure. Clin Nephrol S42-S47.
12. Tominaga Y, Tanaka Y, Sato K, et al. (1997). Histopathology, pathophysiology and indications for surgical treatment of renal hyperparathyroidism. Seminar Surg Oncol 13:78-86.
13. Tominaga Y, Kohara S, Namii Y, et al. (1996). Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism. World J Surg 20:744-750.
14. Tominaga Y, Tsuzuki T, Uchida K, et al. (1999). Expression of PRAD1/cyclinD1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma. Kidney Int 55:1375-1383.
15. Tominaga Y, Tanaka Y, Sato K, et al. (1992). Recurrent renal hyperparathyroidism and DNA analysis of autografted parathyroid tissue. World J Surg 16:595-603.
16. Tominaga Y, Takagi H (1999). Mechanism of parathyroid tumorigenesis in uremia. Nephrol Dial Transplant 14 Suppl. 63-65.
17. Tominaga Y, Takagi H (1996). Molecular genetics of hyperparathyroid disease. Curr Opin Nephrol Hypertens 5:336-341.
18. Tominaga Y, Numano M, Uchida K, Katayama A, Haba T, Asano H, Sato K, Tanaka Y, Takagi H (1994). Parathyroidectomy for patients with renal hyperparathyroidism refractory to calcitriol pulse therapy. J Bone Miner Met 12 Suppl. 1:S99-S104.
19. Tominaga Y, Inaguma D, Matsuoka S, Tahara H, Kukita K, et al. (2006). Is the volume of the parathyroid gland a predictor of Maxacalcitol response in advanced secondary hyperparathyroidism? Ther Aphre Dial 10:198-204.
20. Giangrande A, Castiglione A, Solbiasti L, Allaria P (1992). Ultrasound guided percutaneous fine-needle ethanol injection into parathyroid glands in secondary hyperparathyroidism. Nephrol Dial Transplant 7:412-421.
21. Matsuoka S, Tominaga Y, Ueki T, Goto N, katayama A, Haba T, Uchida K, Nakao A (2003). Relationship between size estimated by ultrasonography and hyperplastic pattern of parathyroid glands in patient with renal hyperparathyroidism. Nephrol Dial Transplant 18 Suppl. 4 :139.
22. Fukagawa M, Kitaoka M, Yi H et al. (1994). Serial evaluation of parathyroid size by ultrasonography is another useful marker for long-term prognosis of calcitriol pulse therapy in chronic dialysis patients. Nephron 68:221-228.
23. Katoh N, Nakayama M, Shigematsu T et al. (2000). Presence of sonographically detectable parathyroid glands can predict resistance to oral pulsed-dose calcitriol treatment of secondary hyperparathyroidism. Am J Kidney Dis 35:465-468.
24. Okuno S, Ishimure E, Kitatani K, Chou H, Nagasue K, Maekawa K, Izumotani T, Yamakawa T, Imanishi Y, Shoji T, Inaba M, Nishizawa Y (2003). Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism. Nephrol Dial Transplantation 18:2613-2621.
25. Indriason OS, Quarles LD (2000). Comparison of treatments for mild secondary hyperparathyroidism in hemodialysis patients. Kidney Int 57:282-292.
26. Chertow G, Burke ST, Raggi P et al. (2002), Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62:245-252.
27. Slatoplosky E, Dusso A, Brown AJ (2002). Control of uremic bone disease: Role of vitamin D analogs. Kidney Int 61 Suppl. 80:S143-S148.
28. Murayama E, Miyamoto K, Kubodera N et al. (1986). Synthetic studies of vitamin D3 analogues. VIII. Synthesis of 22-oxavitamin D3 analogues. Chem Pharm Bull 34:4410-4413.
29. Hirata M, Endo K, Ohkawa H, Katsumata K, Ichikawa F, Kubodera N, Fukagawa M (2002). A comparison between 1,25-dihydroxy-22-oxavitamin D3 and 1,25-dihydroxyvitamin D3 regarding suppression of parathyroid hormone secretion and calcaemic action. Nephrol Dial Transplantation 17 (Suppl. 10):41-45.
30. Koike N, Hayakawa N, Tokuda K, Nishimiya K, Saito K, Stumpf WE (2002). In vivo time-course of receptor binding in the parathyroid gland of the vitamin D analogue (3H)1,25-dihydroxy-22-oxavitamin D3 compared with (3H) 1,25-dihydroxyvitamin D3, determined by micro-autoradiography. Nephrol Dial Transplantation 17(Suppl. 10):53-57.
31. Akizawa T, Suzuki M, Akiba T, Nishizawa Y, Kurokawa K (2001). Clinical effects of maxacalcitol on secondary hyperparathyroidism of uremic patients. Am J Kidney Dis 38 Suppl. 1:S147-S151.
32. Ming T, Myles W, Edmund L, et al. (2003). Survival of patients undergoing hemodialysis with paricalcitol or calcitriol. N Engl J Med. 349:446-456.
33. Block GA, Martin KJ, Francisco ALM, Turner SA, Avram MM (2004). Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med. 350:1516-1525.
34. National Kidney Fundation (2003). K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis Suppl. 42:S1-S202.
35. Tominaga Y, Numano M, TanakaY, Uchida K, Takagi H (1997). Surgical treatment of renal hyperparathyroidism. Semin Surg Oncol 13:87-96.
36. Tominaga Y (1999). Surgical management of secondary hyperparathyroidism in uremia. Am J Med Sci 317:390-397.
37. Tominaga Y (2000). Management of renal hyperparathyroidism. Biomed Phamacother. 54 Suppl.1:25S-31S.
38. Tominaga Y, Matsuoka S, Sato T (2005). Surgical indications and procedures of parathyroidectomy in patients with chronic kidney disease. Ther Apher Dial 9: 44-47.
39. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM (2004). Mineral metabolism, mortality, and morbidity in maintenance hemodialysis patients. J Am Soc Nephrol 15:2208-2218.
40. Block GA, Hulbert-Shearon TE, Levin NW, Port FK (1998). Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31:601-617.
41. Moe SM, O'Neill KD, Duan D et al. (2002). Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 61:638-647.
42. Tominaga Y (2001). Uremic calciphylaxis syndrome: calcified uremic artheriolopathy. Int Med 40:1174-1175.
43. Matsuoka S, Tominaga Y, Uno N, Goto N, Sato T, Katayama A, et al. (2005). Calciphylaxis: a rare complication of patients who required parathyroidectomy for advanced renal hyperparathyroidism. World J Surg. 29:632-635.
44. Medical Expert Group (Chair: Cannata-Andia JB, and Drueke TB) (2000). Clinical algorithms on renal osteodystrophy. Nephrol Dial Transplant15 (Suppl. 5) 39-57.
45. Takagi H, Tominaga Y, Uchida K et al. (1984). Subtotal versus total parathyroidectomy with forearm autograft for secondary hyperparathyroidism in chronic renal failure. Ann Surg 200:18-23.
46. Rothmund M, Wagner PK, Schark C, (1991). Subtotal parathyroidectomy versus total parathyroidectomy and autotransplantation in secondary hyperparathyroidism: A randomized trial. World J Surg 15:745.
47. Takagi H, Tominaga Y, Tanaka Y, Uchida K, orihara A, et al. (1988). Total parathyroidectomy with forearm autograft for secondary hyperparathyroidism in chronic renal failure. Ann Surg 208:639-644.
48. Tominaga Y, Uchida K, Haba T, Katayama A, Sato T, Hibi Y, Numano M, Tanaka Y, Inagaki H, Watanabe I, Hachisuka T, Takagi H (2001). More than 1,000 cases of total parathyroidectomy with forearm autograft for renal hyperparathyroidism. Am J Kidney Dis 38 (Suppl.): S166-S171.
49. Takagi H, Tominaga Y, Uchida K, Yamada N, Kawai M, Kano T, et al. (1986). Evaluation of image-diagnosing methods of enlarged parathyroid glands in chronic renal failure. World J Surg 10:605-611.
50. Tanaka Y, Tominaga Y, Funahashi H, Sato K, Numano M, et al. (1996). Preoperative localization studies in secondary hyperplasia. Acta Chir Austriaca Suppl. 124:14-16.
51. Numano M, Tominaga Y, Uchida K. et al. (1998). Surgical significance of supernumerary parathyroid glands in renal hyperparathyroidism. World J Surg 22:1098-1103.
52. Pattou FN, Pellissier LC, Neol C, et al. (2000). Supernumerary parathyroid glands: frequency and surgical significance in treatment of renal hyperparathyroidism. World J Surg. 24:1330-1334.
53. Akerstrom G, Malmaeus J, Bergstrom R (1984). Surgical anatomy of human parathyroid glands. Surgery 95:14-21.
54. Weber T, Zeier M, Hinz U, Schilling T, Buchler M (2005). Impact of intraoperative parathyroid hormone levels on surgical results in patients with renal hyperparathyroidism. World J Surg 29:1176-1179.
55. Wells SA Jr, Gunnels JC, Shelburne JD, et al. (1975). Transplantation of the parathyroid glands in man: clinical indications and results. Surgery 78:34-44.
56. Tanaka Y, Funahashi H, Imai T, Tominaga Y, Takagi H (1997). Parathyroid function and bone metabolic markers in primary and secondary hyperparathyroidism. Seminar Surg Oncol 13:125-133.
57. Chou FF, Chen JB, Lee Ch, et al. (2000). Parathyroidectomy can improved bone mineral density in patients with symptomatic secondary hyperparathyroidism in dialysis patients: Recommendation for a change in management. Am J Kidney Dis 35:1226-1237.
58. Yajima A, Ogawa Y, Takahashi HF, Tominaga Y, Inou T, Otsubo O (2003). Changes of bone remodeling immediately after parathyroidectomy for secondary hyperparathyroidism. Am J Kidney Dis42:729-738.
59. Goto N, Tominaga Y, Matsuoka S, et al. (2005). Cardiovascular complications caused advanced secondary hyperparathyroidism in chronic dialysis patients;specifical focus on dilated cardiomyopathy. Clin Exp nephrol 9:138-141.
60. Kestenbaum B, Andress DL, Schwartz SM, Gillen DL, Seliger SL, et al. (2004). Survival following parathyroidectomy among United States dialysis patients Kidney Int 66:2010-2016.
61. Tominaga Y, Ueki T, Goto N, et al. (2003). Long-term results of parathyroidectomy for advanced renal hyperparathyroidism. J Am Soc Nephrol 14:685A.
62. Tominaga Y, Uchida K, Haba T, et al. (1998). Thyroid lesions in patients with renal hyperparathyroidism. Thyroidl Clin Exp. 10:275-277.
63. Tominaga Y, Katayama A, Sato T, et al. (2003). Re-operation is frequently required when parathyroid glands remain after initial parathyroidectomy for advanced secondary hyperparathyroidism in uraemic patients. Nephrol Dial Transplant 18:iii65-70.
64. Hibi Y, Tominaga Y, Uchida K, Takagi H, Imai T, Funahashi H, et al. (2002). Cases with fewer than four parathyroid glands in patients with renal hyperparathyroidism at initial parathyroidectomy. World J Surg. 26:314-317.
65. Hibi Y, Tominaga Y, SatoT, et al. (2002). Reoperation for renal hyperparathyroidism. World J Surg. 26:1301-1307.
66. Hibi Y, Tominaga Y, Uchida K et al. (2001). Preoperative imaging diagnosis for persistent renal hyperparathyroidism. Asian J Surg 24:153-159.
67. De-Francisco AL, Amado JA, Casanova D, et al. (1991). Recurrence of hyperparathyroidism after total parathyroidectomy with autotransplantation: a new technique to localize source of hormone excess. Nephron 58:306-309.
68. Matsuoka S, Tominaga Y, Uno N, Goto N, Sato T, Katayama A., et al. Surgical significance of undescended parathyroid gland in renal hyperparathyroidism. Surgery (in press)
69. Fukagawa M, Kitaoka M, Tominaga Y, Akizawa T, Kurokawa K (1999). Selective percutaneous etanol injection therapy (PEIT) of the parathyroid in chronic dialysis patients - the Japanese strategy. Nephrol Dial Transplant 14:2574-2577.
70. Kitaoka M (2003). Ultrasonographic diagnosis of parathyroid glands and percutaneous ethanol injection therapy. Nephrol Dial Transplantation. 18 Suppl. 3:iii27-iii30.
71. Cattan P Halimi B, Aidan K et al. (2000). Reoperation for secondary uremic hyperparathyroidism: Are technical difficulties influenced by initial surgical procedure? Surgery 127:5620-5625.
72. Akerstrom G, Rudberg C, Grimelius L, Rastad J (1998). Recurrent hyperparathyroidism due to preoperative seeding of neoplastic or hyperplastic parathyroid tissue. Acta Chir Scand 154:549-552.
73. Stehman-Breen C, Muirhead N, Thorning D et al. (1996). Secondary hyperparathyroidism complicated by parathyromatosis. Am J Kidney Dis 28:502-507.
74. Tominaga Y, Numano M, Uchida K, et al. (1995). Lung metastasis from parathyroid carcinoma causing recurrent renal hyperparathyroidism in a hemodialysis patients: report of a case. Surg Today 25:984-986.
75. Miki H, Sumitomo M, Inoue H, et al. (1996). Parathyroid carcinoma in patients with chronic renal failure on maintenance hemodialysis. Surgery 120:897-901.
76. Tseng CC, Huang JJ, Wang MC et al. (1999). Parathyroid carcinoma with multiple lung metastases. Nephrol Dial Transplant 14:449-451.
77. Khan MW, Worcester EM, Straus II FH, Khan S, Staszak V, Kaplan EL (2004). Parathyroid carcinoma in secondary and tertiary hyperparathyroidism. J Am Coll Surg 199:312-318.
78. Uchida K, Tominaga Y, Tanaka Y, Takagi H (1997). Renal transplantation and secondary hyperparathyroidism . Seminar Surg Oncol 13;97-103.
79. Tominaga Y, Uchida K, Sato K, et al. (1992). Parathyroidectomy before and after renal transplantation. Transplant Proc 24:1861-1862.